CHELMSFORD, Mass., April 26, 2021 /PRNewswire/ -- Brooks
Automation, Inc. (Nasdaq: BRKS) today announced that it has entered
a definitive agreement to acquire Precise Automation, Inc., a
leading developer of collaborative robots and automation subsytems
headquartered in Fremont, CA. The total cash purchase price
for the acquisiton will be approximately $70
million, subject to working capital and other
adjustments. The transaction is expected to close by the end
of April upon satisfaction of customary closing
conditions.
Precise Automation's proprietary technology enables human-robot
workflows in a safe and easy-to-use manner, automating processes
that could not be addressed practically in the past. The company's
collaborative robots, which include SCARA, 6-axis and Cartesian
configurations, are delivered fully assembled and designed for easy
system integration by end users and OEM customers. Precise
Automation's products are used in a variety of end markets
including laboratory automation and semiconductor and electronics
manufacturing. Laboratory automation applications include drug
discovery, analytical laboratory, clinical diagnostics, and
genomics.
Steve Schwartz, President and CEO
of Brooks commented, "Precise provides Brooks with a product
offering and technology portfolio that is well positioned to take
advantage of the exciting growth opportunities in the collaborative
robot market. Their history of innovation in vision technology,
precision motion, integrated controllers and direct drive motors
and track record of solving customer challenges in laboratory and
semiconductor automation makes Precise a great fit with
Brooks."
Co-founders Brian Carlisle and
Dr. Bruce Shimano, two industry
visionaries with over 35 years each of robotics experience, will
join Brooks and continue to lead Precise Automation reporting to
Dave Jarzynka, President of the
Brooks Semiconductor Solutions Group. Precise Automation
generated $17 million in revenue over
the last twelve months. The Company expects the
acquisition to be immediately accretive to earnings.
About Brooks Automation
Brooks (Nasdaq: BRKS) is a
leading provider of life science sample-based solutions and
semiconductor manufacturing solutions worldwide. With over 40
years as a partner to the semiconductor manufacturing industry,
Brooks is a provider of industry-leading precision vacuum robotics,
integrated automation systems and contamination control solutions
to the world's leading semiconductor chip makers and equipment
manufacturers. The Company's Life Sciences business provides a full
suite of reliable cold-chain sample management solutions and
genomic services across areas such as drug development, clinical
research and advanced cell therapies for the industry's top
pharmaceutical, biotech, academic and healthcare institutions
globally. Brooks Life Sciences' GENEWIZ division is a leading
provider of gene sequencing and gene synthesis services.
Brooks is headquartered in Chelmsford,
MA, with operations in North
America, Europe and
Asia. For more information, visit www.brooks.com.
"Safe Harbor Statement" under Section 21E of the Securities
Exchange Act of 1934
Some statements in this release are
forward-looking statements made under Section 21E of the Securities
Exchange Act of 1934. These statements are neither promises nor
guarantees but involve risks and uncertainties, both known and
unknown, that could cause Brooks' financial and business results to
differ materially from our expectations. They are based on the
facts known to management at the time they are made. These
forward-looking statements include but are not limited to
statements about the benefits of the Company's acquisition of
Precise Automation and the expected value of the acquisition to the
Company. Factors that could cause results to differ from our
expectations include the following: the impact of the
COVID-19 global pandemic on the markets we and Precise Automation
serve; uncertainties in global political and economic conditions,
our ability to integrate the acquired business and other factors
and other risks, including those that we have described in our
filings with the Securities and Exchange Commission, including but
not limited to our Annual Report on Form 10-K, current reports on
Form 8-K and our quarterly reports on Form 10-Q.
INVESTOR CONTACTS:
Sara Silverman
Director, Investor Relations
Brooks Automation
978.262.2635
sara.silverman@brooks.com
Sherry Dinsmore
Brooks Automation
978.262.4301
sherry.dinsmore@brooks.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/brooks-announces-agreement-to-acquire-precise-automation-301276393.html
SOURCE Brooks Automation